Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research
International Journal of Molecular Sciences · 11.09.2024 · 25 (18) · 9834
DOI: 10.3390/ijms25189834 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.09.2024. Verfasst von Irene González-Guede und 2 weiteren Autor:innen. Beteiligte Einrichtung: UGC de Reumatología, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Osteoarthritis, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: INSTITUTO DE SALUD CARLOS III, ISCIII.
Abstract (Originalsprache)
The existing in vitro and in vivo models for studying osteoarthritis have significant limitations in replicating the complexity of joint tissues. This research aims to validate a Tissue-On-a-Chip system for osteoarthritis research. Osteochondral tissues obtained from knee replacement surgeries of patients with osteoarthritis were cultured in an Organ-On-a-Chip system. This system was designed to supply oxygen and glucose to the cartilage from the bone. The distribution of oxygen and glucose was evaluated by fluorescence using Image-iT Green Hypoxia and 2-NBDG, respectively. Cytotoxicity was measured using lactate dehydrogenase (LDH) levels in chip cultures compared to plate cultures (12 tissues per method). Glycosaminoglycans (GAGs), alkaline phosphatase (ALP), Coll2-1, and procollagen type II N-terminal propeptide (PIINP) were measured in the perfused medium of the Tissue-On-a-Chip over a period of 70 days. Fluorescence of Image-iT Green Hypoxia was observed only in the cartilage area, while 2-NBDG was distributed throughout the tissue. An increase in LDH levels was noted in the plate cultures on day 24 and in the Tissue-On-a-Chip cultures on day 63. Compared to the start of the culture, GAG content increased on day 52, while ALP showed variations. A notable increase in GAG, ALP, and Coll2-1 levels was observed on day 59. PIINP levels remained stable throughout the experiment. The validated osteochondral Tissue-On-a-Chip system can replicate the joint microenvironment, with hypoxic conditions in cartilage and normoxic conditions in bone. Tissue survival and component stability were maintained for approximately two months. This platform is a useful tool for evaluating new drugs and represents a viable alternative to animal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UGC de Reumatología, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.
- UGC de Traumatología y Cirugía Ortopédica, Hospital Clínico San Carlos, IdISSC, 28040 Madrid, Spain.
- Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
ORCID-Profile: Irene González-Guede, Daniel Garriguez-Perez, Benjamin Fernandez-Gutierrez
Förderung
- INSTITUTO DE SALUD CARLOS III
- ISCIII
Zitieren
APA
González-Guede, I., Garriguez-Perez, D., & Fernandez-Gutierrez, B. (2024). Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research. International Journal of Molecular Sciences, 25(18), 9834. https://doi.org/10.3390/ijms25189834
Vancouver
González-Guede I, Garriguez-Perez D, Fernandez-Gutierrez B. Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research. International Journal of Molecular Sciences. 2024;25(18):9834. doi:10.3390/ijms25189834
BibTeX
@article{GonzlezGuede2024,
author = {González-Guede, Irene and Garriguez-Perez, Daniel and Fernandez-Gutierrez, Benjamin},
title = {Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {18},
pages = {9834},
doi = {10.3390/ijms25189834}
}
EUVIMED